tirzepatide weight loss mechanism of action (Mounjaro/Zepbound): Research Guide Tirzepatide - an overview |

Strategy 3: Consider Licensed Compounded Semaglutide For patients without commercial insurance and ineligible for Medicaid, compounded semaglutide 2.4 mg through a PCAB-accredited Michigan 503A pharmacy at ~$199/month offers clinically equivalent active ingredient at a substantially lower price, with the caveats about compounding oversight described above

The initial tirzepatide dose in both cohorts was 2.5 mg, which was increased by 2.5 mg every 4 weeks to a maximum final dose of 10.0 mg at week 16 (Cohort 1) or 15.0 mg at week 24 (Cohort 2)

This predictable cost structure makes it easier to commit to the long-term monitoring and lifestyle changes that support both weight loss and liver recovery

This allows for a targeted treatment plan for conditions like severe GERD, IBS, gallbladder issues, or oesophageal spasms